Correct microarray analysis approaches in 'Hsa-circRNA11783-2 in peripheral blood is correlated with coronary artery disease and type 2 diabetes mellitus'

Area of Science:

• Genomics
• Cardiovascular Science
• Endocrinology

Background:

• Investigates the role of Hsa-circRNA11783-2 in coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM).
• Examines the relationship between circular RNA expression and these complex diseases.

Discussion:

• Critiques the statistical methodology used for differential expression analysis in the original study.
• Highlights concerns regarding the use of unadjusted p-values and fold-change thresholds in microarray data analysis.
• Emphasizes the need for rigorous statistical methods to mitigate false positives in high-throughput expression studies.

Key Insights:

• The association between Hsa-circRNA11783-2, CAD, and T2DM warrants further investigation.
• Current bioinformatics analysis lacks sufficient statistical rigor for reliable differential expression findings.
• Accurate identification of differentially expressed circular RNAs is crucial for understanding disease mechanisms.

Outlook:

• Recommends employing robust statistical approaches for analyzing microarray data in future studies.
• Suggests refining analysis methods to ensure the reliability of identified biomarkers.
• Further research is needed to validate the role of Hsa-circRNA11783-2 in CAD and T2DM pathogenesis.